On-Demand
The CRDMO Advantage: From Supply Chain Efficiency to Patient-Centric Value Chain
Watch Now
The CRDMO advantage: From supply chain efficiency to patient-centric value chain
Increased collaborations between CDMOs and CROs reflect and support this shift, according to a 2023 trend report titled "The Nexus Between Patient and Big Pharma" developed by Thermo Fisher Scientific in partnership with CPHI.
This webinar will explore the key findings from the report, focusing specifically on the CDMO and CRO synergies that can be leveraged to streamline drug development and accelerate the delivery of safe, effective, high-quality treatments to patients.
Join us, as you will learn:
- How intentional CDMO/CRO partnerships are the key to forging a future that's inherently patient-centric
- Strategies for leveraging a combined CRDMO (Contract Research and Development Manufacturing Organization) to simplify pathways from discovery through to market
- The critical role of the supply chain in clinical studies and the role of the clinical site in the value chain
- Effective methods for empowering clinical sites to prioritize patient needs, minimizing the impact of supply chain disruptions on clinical operations and patient care
Meet the Speakers

Tara Dougal

Brenda Bruker

Melinda Santikham
Reserve your spot today –
register now to attend!
By completing this form You agree Citeline and Thermo Fisher Scientific Inc. may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and Thermo Fisher Scientific Inc.